AquaNab secures funding for nanoantibody platform

Heeyuu Pulse was unable to corroborate details concerning the biotechnology startup AquaNab, its reported funding for a nanoantibody platform, or its focus on preventing and treating diseases such as sea lice in aquaculture, based on the provided research materials. The supplied information primarily covers topics such as AI-driven discovery in industrial biomanufacturing, a Ukrainian video game, AI automation in financial services, and sepsis treatment technologies. Consequently, an article detailing AquaNab's recent investment and technological advancements cannot be constructed using the given facts.